Myofibroblast-derived PDGF-BB promotes Hedgehog survival signaling in cholangiocarcinoma cells.
Myofibroblast-derived PDGF-BB promotes Hedgehog survival signaling in cholangiocarcinoma cells.
复制标题
DOI:
10.1002/hep.24588
复制
发表时间:
2011-12
期刊:
影响因子:
13.5
通讯作者:
Gores, Gregory J.
中科院分区:
文献类型:
--
作者:
Fingas, Christian D.;Bronk, Steven F.;Werneburg, Nathan W.;Mott, Justin L.;Guicciardi, Maria E.;Cazanave, Sophie C.;Mertens, Joachim C.;Sirica, Alphonse E.;Gores, Gregory J.
Cholangiocarcinoma (CCA) cells paradoxically express the death ligand TRAIL, and, therefore, are dependent upon potent survival signals to circumvent TRAIL cytotoxicity. CCAs are also highly desmoplastic cancers with a tumor microenvironment rich in myofibroblasts (MFBs). Herein, we examine a role for MFB-derived CCA survival signals. We employed human KMCH-1, KMBC, HuCCT-1, TFK-1, and Mz-ChA-1 CCA cells as well as human primary hepatic stellate and myofibroblastic LX-2 cells for these studies. In vivo experiments were conducted using a syngeneic rat orthotopic CCA model. Co-culturing CCA cells with myofibroblastic human primary HSCs or LX-2 cells significantly decreased TRAIL-induced apoptosis in CCA cells, a cytoprotective effect abrogated by neutralizing PDGF-BB-antiserum. Cytoprotection by PDGF-BB was dependent upon Hedgehog (Hh) signaling as it was abolished by the smoothened (the transducer of Hh signaling) inhibitor cyclopamine. PDGF-BB induced PKA-dependent trafficking of smoothened to the plasma membrane resulting in GLI2 nuclear translocation and activation of a consensus GLI reporter gene-based luciferase assay. A genome-wide mRNA expression analysis identified 67 target genes to be commonly up- (50 genes) or downregulated (17 genes) by both SHH and PDGF-BB in a cyclopamine-dependent manner in CCA cells. Finally, in a rodent CCA in vivo-model, cyclopamine administration increased apoptosis in CCA cells resulting in tumor suppression. Myofibroblast-derived PDGF-BB protects CCA cells from TRAIL cytotoxicity by a Hh signaling-dependent process. These results have therapeutical implications for the treatment of human cholangiocarcinoma.
登录
查看更多内容
影响因子:
13.5
作者:
Dranoff, Jonathan A.;Wells, Rebecca G.
通讯作者:
Wells, Rebecca G.
DOI:
10.1073/pnas.0401064101
发表时间:
2004-04-06
影响因子:
11.1
作者:
Kuperwasser, C;Chavarria, T;Weinberg, RA
通讯作者:
Weinberg, RA
影响因子:
4.8
作者:
Deming, Paula B.;Campbell, Shirley L.;Howe, Alan K.
通讯作者:
Howe, Alan K.
影响因子:
13.5
作者:
Blechacz, Boris;Gores, Gregory J.
通讯作者:
Gores, Gregory J.
影响因子:
2.4
作者:
Fingas, Christian Dominik;Katsounas, Antonios;Canbay, Ali
通讯作者:
Canbay, Ali